NCT03070678View on ClinicalTrials.gov

Interaction Study to Evaluate the Effects of Mefenamic Acid on the Pharmacokinetics and Pharmacodynamics of Sotagliflozin in Healthy Male and Female Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

March 14, 2017

Primary Completion Date

April 18, 2017

Study Completion Date

April 18, 2017

Conditions
Diabetes Mellitus
Interventions
DRUG

Sotagliflozin (SAR439954)

"Pharmaceutical form: tablet~Route of administration: oral"

DRUG

Mefenamic acid

"Pharmaceutical form: capsule~Route of administration: oral"

Trial Locations (1)

Unknown

Investigational site 250001, Gières

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY